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Introduction 
Osteoarthritis (OA) is the most common form of arthritis and accounts 
for 50% of all chronic conditions in the elderly. One in two adults 
reported a chronic musculoskeletal condition in 2005, twice the rate of 
reported chronic heart or respiratory conditions(2). In addition, persons 
aged 45 to 64 account for an increasingly greater proportion of total 
musculoskeletal disease treatment costs and lost wages, a trend that will 
continue for the next several decades(3). Surgical treatment culminating 
in total joint replacement (TJR) remains the most effective therapy for 
late stage OA. Current treatment of pre-surgical OA consists of pain 
relieving medications (i.e. NSAIDs), physical therapy, and mechanical 
supports (i.e. braces, canes, and walkers). Despite the wealth of clinical 
data on OA, there is currently no cure for the disease. Our previous work 
in developing potential disease-modifying osteoarthritis drugs 
(DMOADs) had yielded promising results, showing a decrease in OA 
cartilage lesion areas and histological grades (Figure 1). Interestingly, 
we noted that animals treated for only the first 3 weeks demonstrated 
near 6-week levels of OA reduction. These differences in treatment 
responsiveness necessitate a better characterization of the specific 
cellular phases of OA throughout the natural disease progression. The 
current study was undertaken to clarify this progression of early OA 
events. 
 
 
Methods 
OA was induced in the right knees of 10-week-old male 129 S6/SvEv 
(Taconic) mice via  DMM surgery. Mice receiving sham surgery with no 
destabilization were used as negative controls.  Both groups were 
sacrificed at 4, 8, 12, 16, and 20-day intervals in order to evaluate OA 
progression. Knees were harvested, processed, and sectioned at 6um 
intervals. Sections were stained for cartilage composition (Safranin-O) 
and scored for progression and severity of OA by 3 blinded observers 
using a 0-5 scale (modified Mankin System)(4). Both ‘mean maximal’ 
scores (highest scores per knee), and ‘mean summed scores (sum of 
scores per knee) were generated using this scale. All scores were 
averaged across observers. Cartilage lesion area, subchondral bone area 
(sclerosis), and apoptosis (TUNEL method) were measured using a 
histomorphometric analysis package (ImageJ)(5). 
 
 
Results 
 
Figure 1.
 
:  Morphometric analyses of one of the individual measures of 
degenerative articular cartilage changes reveals an episodic pattern of 
progression. 
 
 
Figure 2.
 
:  Programmed Chondrocyte Cell Death (Apoptosis) is an acute 
event in experimental OA. 
 
Conclusions  
• Measurable osteoarthritic changes in articular cartilage and 
underlying bone following meniscal injury occur far earlier 
than previously described.  
• Some changes are clearly degenerative (OA grade, stage & 
lesion area), however, some changes (subchondral bone 
thickening) could be regarded as compensatory supportive 
mechanisms.    
• Cell death (apoptosis) is an acute event following relatively 
minor changes to knee biomechanics. 
• Our results suggest an opportunity for intervention early on 
in OA before the resulting articular changes become 
irreversible.  Specifically, consideration of anti-apoptosis 
based therapies could prevent much of the subsequent 
structural changes in articular cartilage. 
 
 
Future Directions 
• Apoptosis data suggests pursuing an anti-apoptotic therapy 
strategy in the DMM model of OA 
• Early bone sclerotic events suggest bone tissue as a target for 
anti-OA therapy. 
• Translationally, preventing or delaying OA due to soft tissue 
injuries (e.g., sports injuries) may be possible with early 
medical treatment of OA proximal to the time of injury. 
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